BIOSYM A/S: Financial statements 2014
CVR: 21774189
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 6,124,737 and a net result of DKK 1,531,251 compared with DKK 554,703 the year before. Equity in the 2014 report amounted to DKK 7,556,585. The solvency ratio was 50.3%.
- Gross Profit
- DKK 6,124,737
- Profit/Loss
- DKK 1,531,251
- Equity
- DKK 7,556,585
- Total Assets
- DKK 15,034,494
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 6.1 mio. | 1.5 mio. | 7.6 mio. | - |
| 2013 | - | -4.7 mio. | 555 t. | -6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 21 employees (2018). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.